Skip to main content
Top
Published in: Supportive Care in Cancer 12/2021

01-12-2021 | Mood Disorders | Review Article

Effects of psychosocial interventions on psychological outcomes among caregivers of advanced cancer patients: a systematic review and meta-analysis

Authors: Jocelyn Zhi Jia Lee, Hui-Chen Chen, Jia Xin Lee, Piyanee Klainin-Yobas

Published in: Supportive Care in Cancer | Issue 12/2021

Login to get access

Abstract

Purpose

This systematic review aimed to synthesize the effectiveness of psychosocial interventions on caregivers of advanced cancer patients, in comparison with usual care, on caregivers’ quality of life (QoL), anxiety, and depression symptoms.

Methods

Comprehensive searches for published and unpublished studies were performed using nine electronic databases, two trial registers, and reference lists of included studies. Two reviewers independently screened, appraised, and extracted data. The Cochrane risk of bias tool was used to appraise the methodological quality of included studies, while the Cochrane data extraction tool was used to elicit relevant information. Meta-analysis, narrative analysis, and sensitivity analysis were conducted to synthesize data. Standardized mean differences (SMD) represented effects of psychosocial interventions.

Results

Fifteen randomized controlled trials were included in this review. At post-intervention, findings revealed a significant small pooled effect size (SMD = 0.45) on QoL and significant moderate effect on depression (SMD = − 0.65). However, a small non-significant pooled effect size was observed on anxiety (SMD = − 0.24). At follow-up assessments, effect sizes of all outcomes were small and non-significant. Overall quality of evidence was rated very low for all outcomes and most studies had unclear or high risk of bias. Thus, results should be interpreted with caution.

Conclusion

Psychosocial interventions were effective in improving QoL and depression among caregivers of persons with advanced cancer. However, future randomized control trials with lower risk of bias, larger sample size, detailed participant characteristics, and informative interventions are desirable.
Appendix
Available only for authorised users
Literature
21.
go back to reference Cohen J (1988) Statistical power analysis in the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Inc., Hillsdale Cohen J (1988) Statistical power analysis in the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Inc., Hillsdale
28.
32.
go back to reference von Heymann-Horan A, Bidstrup P, Guldin MB, Sjøgren, Andersen EAW, von der Maase H, Johansen C (2018) Effect of home-based specialised palliative care and dyadic psychological intervention on caregiver anxiety and depression: a randomised controlled trial. Br J Cancer 119(11):1307–1315. https://doi.org/10.1038/s41416-018-0193-8CrossRef von Heymann-Horan A, Bidstrup P, Guldin MB, Sjøgren, Andersen EAW, von der Maase H, Johansen C (2018) Effect of home-based specialised palliative care and dyadic psychological intervention on caregiver anxiety and depression: a randomised controlled trial. Br J Cancer 119(11):1307–1315. https://​doi.​org/​10.​1038/​s41416-018-0193-8CrossRef
Metadata
Title
Effects of psychosocial interventions on psychological outcomes among caregivers of advanced cancer patients: a systematic review and meta-analysis
Authors
Jocelyn Zhi Jia Lee
Hui-Chen Chen
Jia Xin Lee
Piyanee Klainin-Yobas
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06102-2

Other articles of this Issue 12/2021

Supportive Care in Cancer 12/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine